Nexalin Technology

NXLNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$3.840 M

$4.63 +8.43%

Close of 22 Sept 2026

Revenue

$301.6K

#3553 by revenue

Earnings

-$8.22M

Loss-making

Shares outstanding

22,036,402

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#24IridexIRIX$11.2M
#25ENDRA Life SciencesNDRA$9.34M
#26Nexalin TechnologyNXL$3.84M
#27Valion BioVBIO$3.20M
#28NuwellisNUWE$3.01M

What if Nexalin Technology were worth as much as…

Open the what-if tool →

Gold $30.2T

$36,452,821

Per share 7,873,179× higher

Bitcoin $1.74T

$2,099,898

Per share 453,542× higher

Nvidia $5.52T

$6,650,310

Per share 1,436,352× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Nexalin Technology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.